Ask your provider about discontinuation protocols, expected metabolic changes, and monitoring plans if you're diabetic or have gestational diabetes risk
Liraglutide was associated primarily with reduced risk of worsening depression
However, the substantial weight loss they facilitate does result in some loss of lean body mass, as occurs with any significant weight reduction
Therefore, glucose dysregulation in the postoperative period will be solely related to the lack of endocrine effects from GLP-1 agonists in patients who temporarily pause these medications
History of disordered eating pre-meal appetite-blunting practices can become restriction rituals
Holly Lofton from NYU Grossman School of Medicine highlights: "If a patient has recurrence of a previously resolved medical condition or if they gain more than 5% weight above their goal weight, then they are likely to continue to gain weight [and may need to restart]." This personalized approach ensures your tapering process is carefully monitored and adjusted as needed
